1. Home
  2. AMWL vs CRVS Comparison

AMWL vs CRVS Comparison

Compare AMWL & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$5.38

Market Cap

92.0M

Sector

Technology

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$13.02

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
CRVS
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.0M
1.7B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
AMWL
CRVS
Price
$5.38
$13.02
Analyst Decision
Hold
Strong Buy
Analyst Count
7
5
Target Price
$7.42
$28.20
AVG Volume (30 Days)
65.1K
1.1M
Earning Date
04-30-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
57.06
48.04
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$2.54
52 Week High
$9.15
$26.95

Technical Indicators

Market Signals
Indicator
AMWL
CRVS
Relative Strength Index (RSI) 55.96 31.18
Support Level $4.48 $6.65
Resistance Level $5.81 $18.73
Average True Range (ATR) 0.35 1.06
MACD -0.02 -0.43
Stochastic Oscillator 59.09 1.32

Price Performance

Historical Comparison
AMWL
CRVS

About AMWL American Well Corporation

American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: